GLOVES DEMAND SET TO SURGE FURTHER FOR A FEW YEARS
This time around it is not the same as the previous round. Hartalega and other glove stocks has gone through massive selling on the news of vaccine rollout and its efficacy of reducing the spread of COVID cases. This has caused funds to create a selling pressure on glove stocks for a good period of time resulting in glove stocks being deeply undervalued.
What we have seen so far is far from what was expected as COVID cases are still on the rise worldwide and countries are going back into lockdown despite the vaccine innoculation.
And from the QR prospects, we can see the gloves demand are still high
THE OVERALL PROJECTED GROWTH IN DEMAND IS EXPECTED TO OUTSTRIP SUPPLY FOR THE NEXT FEW YEARS
I think all the 4 glove kings are overpriced. Take HARTA for example, market cap per annual production is around RM1.00 per piece of glove produced. Recently KLK said they are venturing into medical glove (currently produce non-medical gloves). By investing 200 million, they can produce 4.5 billion PCs annually, meaning RM0.05 per piece of glove produced. RM1.00 compare to RM0.05, that is 20 times difference. We may say HARTA is better in term of efficiency and profit margin, but a 20 times difference is too much. Some more KLK has rubber estate, and its mother BKAWAN now already acquired CCM, and have all the chemicals for glove manufacturing.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
gemfinder
6,880 posts
Posted by gemfinder > 2021-01-25 23:12 | Report Abuse
History wil repeat. Selling never ends